Cymulate
United States
- Dallas, Texas
- 06/09/2022
- Series D
- $70,000,000
For companies that want to manage their security posture against the evolving threat landscape: Cymulate SaaS-based Extended Security Posture Management (XSPM) deploys within an hour, enabling security professionals to continuously challenge, validate and optimize their cyber-security posture end-to-end across the MITRE ATT&CK® framework.
The platform provides out-of-the-box, expert, and threat intelligence-led risk assessments that are simple to deploy and use for all maturity levels, and constantly updated. It also provides an open framework to create and automate red and purple teaming by generating penetration scenarios and advanced attack campaigns tailored to their unique environments and security policies. Cymulate allows professionals to manage, know and control their dynamic environment.
- Industry Computer & Network Security
- Website https://cymulate.com/
- LinkedIn https://www.linkedin.com/company/cymulate/
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)